These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

114 related items for PubMed ID: 2518157

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Flutamide for prostate cancer.
    Med Lett Drugs Ther; 1989 Jul 28; 31(797):72. PubMed ID: 2501635
    [No Abstract] [Full Text] [Related]

  • 3. Combined androgen blockade: leuprolide and flutamide versus leuprolide and placebo.
    Crawford ED, Goodman P, Blumenstein B.
    Semin Urol; 1990 Aug 28; 8(3):154-8. PubMed ID: 2119048
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. Luteinizing hormone releasing hormone agonists: the US experience.
    Nabors W, Crawford ED.
    J Int Med Res; 1990 Aug 28; 18 Suppl 1():31-4. PubMed ID: 2108884
    [Abstract] [Full Text] [Related]

  • 8. Combination therapy with flutamide and [D-Trp6, des-Gly-NH2(10)]LHRH ethylamide in stage C and D prostate cancer: today's therapy of choice--rationale and 5-year clinical experience.
    Labrie F, Dupont A, Cusan L, Bélanger A, Giguère M, Labrie C, Lacourcière Y, Monfette G, Emond J.
    Prog Clin Biol Res; 1988 Aug 28; 262():11-63. PubMed ID: 3287388
    [No Abstract] [Full Text] [Related]

  • 9. Endocrine effects of combined treatment with an LHRH agonist in association with flutamide in metastatic prostatic carcinoma.
    Bélanger A, Labrie F, Dupont A, Brochu M, Cusan L.
    Clin Invest Med; 1988 Oct 28; 11(5):321-6. PubMed ID: 2972431
    [Abstract] [Full Text] [Related]

  • 10. Effect of adrenalectomy, flutamide, and leuprolide on the growth of the Dunning rat R-3327 prostatic carcinoma.
    Kung TT, Mingo GG, Siegel MI, Watnick AS.
    Prostate; 1988 Oct 28; 12(4):357-63. PubMed ID: 3134647
    [Abstract] [Full Text] [Related]

  • 11. Combination therapy with flutamide and castration (orchiectomy or LHRH agonist): the minimal endocrine therapy in both untreated and previously treated patients with advanced prostate cancer.
    Labrie F, Dupont A, Giguère M, Borsanyi JP, Lacourciere Y, Bélanger A, Lachance R, Emond J, Monfette G.
    Prog Clin Biol Res; 1988 Oct 28; 260():41-62. PubMed ID: 3283766
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Downstaging of localized prostate cancer by neoadjuvant therapy with flutamide and lupron: the first controlled and randomized trial.
    Labrie F, Dupont A, Cusan L, Gomez J, Diamond P, Koutsilieris M, Suburu R, Fradet Y, Lemay M, Têtu B.
    Clin Invest Med; 1993 Dec 28; 16(6):499-509. PubMed ID: 8013155
    [Abstract] [Full Text] [Related]

  • 18. Treatment of advanced prostatic cancer with flutamide.
    Sanford EJ, Bowditch RR, Rohner TJ, Bardin CW.
    Pa Med; 1979 Sep 28; 82(9):29-31. PubMed ID: 386212
    [No Abstract] [Full Text] [Related]

  • 19. The use of flutamide in hormone-refractory metastatic prostate cancer.
    McLeod DG, Benson RC, Eisenberger MA, Crawford ED, Blumenstein BA, Spicer D, Spaulding JT.
    Cancer; 1993 Dec 15; 72(12 Suppl):3870-3. PubMed ID: 8252506
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.